Regional One Health and UTHSC to conduct clinical trials of Regeneron's COVID treatment

A promising potential treatment for COVID-19 will be tested in Memphis. Regional One Health and the University of Tennessee Health Science Center (UTHSC) are collaborating on a clinical trial program for Regeneron’s investigational drug candidate, REGN-COV2. “By enrolling in one of the clinical studies, individuals in our community suffering with COVID-19 symptoms or living with someone with COVID-19 will have the opportunity to gain early access to a potentially life-saving treatment or preventive…